PXD053387 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease |
Description | Pathological deposition of hyperphosphorylated tau in the brain closely correlates with the course of Alzheimer´s disease (AD). Tau pathology occurs first in axons of affected neurons and tau removal from axons might thus be an early intervention strategy. We report that the RNA-binding protein hnRNP R facilitates the axonal localization of the Mapt mRNA encoding tau. Mapt mRNA and tau protein were reduced in axons but not cell bodies of primary neurons cultured from hnRNP R knockout mice. Brains of 5xFAD mice deficient for hnRNP R contained less phospho-tau aggregates and amyloid-β plaques in cortex and hippocampus. Treatment of neurons with antisense oligonucleotides (MAPT-ASOs) to block hnRNP R binding to Mapt similarly reduced axonal tau levels, and intracerebroventricular injection of a MAPT-ASO ameliorated the phospho-tau and plaque load in 5xFAD mice. Lowering of tau selectively in axons thus represents an innovative therapeutic perspective for treatment of AD and other tauopathies. |
HostingRepository | PRIDE |
AnnounceDate | 2025-08-04 |
AnnouncementXML | Submission_2025-08-03_17:10:09.897.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Mario Oroshi |
SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; |
ModificationList | acetylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Astral |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-06-25 01:00:12 | ID requested | |
⏵ 1 | 2025-08-03 17:10:10 | announced | |
Publication List
10.1186/s40035-025-00499-0; |
Zare A, Salehi S, Bader JM, Wiessler AL, Prokesch M, Albrecht V, Villmann C, Mann M, Briese M, Sendtner M, Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer's disease. Transl Neurodegener, 14(1):39(2025) [pubmed] |
Keyword List
submitter keyword: antisense oligonucleotide,Alzheimer´s disease, amyloid, tau, hnRNP R |
Contact List
Matthias Mann |
contact affiliation | Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. |
contact email | mmann@biochem.mpg.de |
lab head | |
Mario Oroshi |
contact affiliation | Proteomics |
contact email | oroshi@biochem.mpg.de |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/08/PXD053387 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD053387
- Label: PRIDE project
- Name: Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease